Assembly Biosciences, Inc. Repayments of Bank Debt
Assembly Biosciences, Inc. (ASMB) reported Repayments of Bank Debt of $800.00 thousand for the 99-month period ending 2013-12-31, per its 10-K filed 2014-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfBankDebt · last filed 2014-03-31
- Assembly Biosciences, Inc. repayments of bank debt for the quarter ending 2012-03-31 was $0.00, a 100.00% decline year-over-year.
- Assembly Biosciences, Inc. repayments of bank debt for the quarter ending 2011-12-31 was $0.00.
- Assembly Biosciences, Inc. repayments of bank debt for the quarter ending 2011-09-30 was $0.00.
- Assembly Biosciences, Inc. repayments of bank debt for the quarter ending 2011-06-30 was $0.00.
- Assembly Biosciences, Inc. repayments of bank debt for fiscal 2013 was $0.00.
- Assembly Biosciences, Inc. repayments of bank debt for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- Assembly Biosciences, Inc. repayments of bank debt for fiscal 2011 was $800.00K.
- Assembly Biosciences, Inc. repayments of bank debt for fiscal 2010 was $0.00.
| Period end | Repayments of Bank Debt 3 month | Repayments of Bank Debt 6 month | Repayments of Bank Debt 9 month | Repayments of Bank Debt 12 month | Repayments of Bank Debt 69 month | Repayments of Bank Debt 72 month | Repayments of Bank Debt 75 month | Repayments of Bank Debt 78 month | Repayments of Bank Debt 87 month | Repayments of Bank Debt 99 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-31 | $800.00K 10-K · filed 2014-03-31 | ||||||||
| 2012-12-31 | $0.00 10-K · filed 2014-03-31 | $800.00K 10-K · filed 2013-03-18 | ||||||||
| 2012-03-31 | $0.00 derived: 10-Q 78 month − 10-K 75 month · filed 2012-05-09 | $0.00 derived: sum of 2 quarters · filed 2013-03-18 | $0.00 derived: sum of 3 quarters · filed 2013-03-18 | $0.00 derived: sum of 4 quarters · filed 2013-03-18 | $800.00K 10-Q · filed 2012-05-09 | |||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-18 | $0.00 derived: sum of 2 quarters · filed 2013-03-18 | $0.00 derived: sum of 3 quarters · filed 2013-03-18 | $800.00K 10-K · filed 2013-03-18 | $800.00K 10-K · filed 2012-03-14 | |||||
| 2011-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2011-11-18 | $0.00 derived: sum of 2 quarters · filed 2011-11-18 | $800.00K 10-Q/A · filed 2011-11-18 | $800.00K 10-Q/A · filed 2011-11-18 | ||||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-15 | $800.00K 10-Q · filed 2011-08-15 | $800.00K 10-Q · filed 2011-08-15 | |||||||
| 2011-03-31 | $800.00K 10-Q · filed 2012-05-09 | |||||||||
| 2010-12-31 | $0.00 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |